Axon Enterprise, Inc. (NASDAQ:AXON) Shares Bought by Cibc World Markets Corp

Cibc World Markets Corp increased its holdings in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 35.1% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 13,118 shares of the biotechnology company's stock after purchasing an additional 3,406 shares during the quarter. Cibc World Markets Corp's holdings in Axon Enterprise were worth $7,796,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Asset Dedication LLC lifted its position in shares of Axon Enterprise by 11.3% during the 4th quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company's stock valued at $106,000 after buying an additional 18 shares in the last quarter. Bleakley Financial Group LLC lifted its holdings in Axon Enterprise by 1.3% during the fourth quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company's stock valued at $908,000 after purchasing an additional 20 shares in the last quarter. Venturi Wealth Management LLC grew its position in shares of Axon Enterprise by 2.7% in the fourth quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company's stock valued at $477,000 after purchasing an additional 21 shares during the period. Insigneo Advisory Services LLC increased its stake in shares of Axon Enterprise by 1.4% during the third quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company's stock worth $627,000 after purchasing an additional 22 shares in the last quarter. Finally, Menard Financial Group LLC increased its stake in shares of Axon Enterprise by 0.8% during the third quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company's stock worth $1,204,000 after purchasing an additional 24 shares in the last quarter. Hedge funds and other institutional investors own 79.08% of the company's stock.

Remove Ads

Analysts Set New Price Targets

Several research firms recently issued reports on AXON. JMP Securities reiterated an "outperform" rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Craig Hallum cut Axon Enterprise from a "buy" rating to a "cautious" rating in a research report on Monday, March 10th. Needham & Company LLC reissued a "buy" rating and issued a $600.00 price objective on shares of Axon Enterprise in a research note on Wednesday, February 26th. TD Cowen assumed coverage on Axon Enterprise in a report on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price objective on the stock. Finally, Barclays reaffirmed a "hold" rating on shares of Axon Enterprise in a report on Monday, March 10th. One research analyst has rated the stock with a sell rating, two have given a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $604.67.

Axon Enterprise Trading Up 0.3 %

Shares of AXON traded up $1.59 during midday trading on Friday, hitting $560.00. 802,214 shares of the stock were exchanged, compared to its average volume of 845,276. Axon Enterprise, Inc. has a 52-week low of $273.52 and a 52-week high of $715.99. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The stock has a fifty day simple moving average of $591.90 and a 200 day simple moving average of $540.96. The firm has a market cap of $42.91 billion, a P/E ratio of 144.70, a P/E/G ratio of 5.17 and a beta of 1.12.

Insider Activity at Axon Enterprise

In related news, insider Jeffrey C. Kunins sold 1,035 shares of the company's stock in a transaction that occurred on Monday, December 23rd. The shares were sold at an average price of $624.47, for a total transaction of $646,326.45. Following the sale, the insider now directly owns 124,243 shares of the company's stock, valued at $77,586,026.21. This represents a 0.83 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Jeri Williams sold 307 shares of the firm's stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the transaction, the director now directly owns 1,627 shares of the company's stock, valued at $899,275.44. This represents a 15.87 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 1,792 shares of company stock worth $1,087,843 in the last three months. 5.70% of the stock is owned by company insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.